Cancer care disparities among Australian and Aotearoa New Zealand Indigenous peoples.


Journal

Current opinion in supportive and palliative care
ISSN: 1751-4266
Titre abrégé: Curr Opin Support Palliat Care
Pays: United States
ID NLM: 101297402

Informations de publication

Date de publication:
01 09 2021
Historique:
pubmed: 8 7 2021
medline: 26 10 2021
entrez: 7 7 2021
Statut: ppublish

Résumé

Persistent and significant inequalities for Indigenous people with cancer around the globe exist, arising from colonial settlement of Indigenous land with profound social, economic and cultural impacts. We summarize recent publications concerning cancer disparities affecting Australian Aboriginal and Torres Strait Islander Peoples and Aotearoa New Zealand Māori Peoples. Cancer-free survival and overall survival statistics testify to the urgent need to 'close the gap'. For Indigenous peoples in Australia and New Zealand, disparity persists along the cancer care pathway, from increased risk factors to lower screening access, health resource utilization and survivorship care. Recent publications highlight multimorbidity as contributing to poor cancer outcomes in Indigenous populations. The implementation of tailored Optimal Care Pathways is described, as is the validation of tailored tools capturing the perspectives of Indigenous persons. Finally, the importance of Indigenous-led research is emphasized. Cancer-specific outcomes in Indigenous people of Australia and New Zealand remain poor with many widening disparities compared to non-indigenous populations. A growing body of epidemiological, health service and clinical research is documenting both the problems and potential solutions. Further work is needed in both broad health policies and the workforce, in building cultural competence to optimize individual care encounters.

Identifiants

pubmed: 34232133
doi: 10.1097/SPC.0000000000000558
pii: 01263393-202109000-00004
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

162-168

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Références

Bartone T. 2018 Ama report card on indigenous health [Internet]. Canberra (ACT): Australian Medical Association; 2018. Available at: https://ama.com.au/system/tdf/documents/2018 AMA Report Card on Indigenous Health_1.pdf?file=1&type=node&id=49617 . [cited 10 May 2021].
Australian Institute of Health and Welfare. Australia's health 2020: in brief [Internet]. 2020; 1–67. Available at: https://www.aihw.gov.au/reports-data/australias-health . [cited 20 May 2021].
Ministry of Health Manatu Haoura. Health and independence report 2017 [Internet]. 2016. Available at: https://www.health.govt.nz/publication/health-and-independence-report-2016 . [cited 15 May 2021].
Paradies Y, Harris R, Anderson I. The impact of racism on indigenous health in Australia and Aotertoa: towards a research agenda. Discuss Pap Ser 2008; (4):1–38.
Gurney J, Stanley J, McLeod M, et al. Disparities in cancer-specific survival between Māori and non-Māori New Zealanders, 2007–2016. JCO Glob Oncol 2020; (6):766–774.
Australian Institute of Health and Welfare (AIHW). Cancer in Aboriginal and Torres Strait Islander people of Australia. Available at: https://www.aihw.gov.au/reports/cancer/cancer-in-indigenous-australians/contents/mortality . [Accessed 13 April 2021]
Howell J, Ward JS, Davies J, et al. Hepatocellular carcinoma in Indigenous Australians: a call to action. Med J Aust 2021; 214:201.e1–202.e1.
Whop LJ, Garvey G, Baade P, et al. The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: a retrospective registry cohort study in Queensland, Australia. Cancer 2016; 122:1560–1569.
Cunningham J, Rumbold AR, Zhang X, Condon JR. Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. Lancet Oncol 2008; 9:585–595.
Garvey G, Cunningham J, Valery PC, et al. Closing the gap — view point closing the gap — view point. Med J Aust 2011; 194:2010–2011.
Brands J, Garvey G, Anderson K, et al. Development of a national aboriginal and torres strait islander cancer framework: a shared process to guide effective policy and practice. Int J Environ Res Public Health 2018; 15:942–958.
Segelov E, Garvey G. Cancer and indigenous populations: time to end the disparity. J Glob Oncol 2020; 2020:80–82.
Sarfati D, Garvey G, Robson B, et al. Measuring cancer in indigenous populations. Ann Epidemiol 2018; 28:335–342.
Chynoweth J, McCambridge MM, Zorbas HM, et al. Optimal cancer care for aboriginal and torres strait islander people: a shared approach to system level change. J Glob Oncol 2020; 6:108–114.
Jaenke R, Butler TL, Condon J, et al. Healthcare provider perspectives on cervical screening for Aboriginal and Torres Strait Islander women: a qualitative study. Aust N Z J Public Health 2021; 45:150–157.
Cunningham J, Garvey G. Are there systematic barriers to participation in cancer treatment trials by Aboriginal and Torres Strait Islander cancer patients in Australia? Aust N Z J Public Health 2021; 45:39–45.
Anderson K, Diaz A, Shaw J, et al. A systematic review of fear of cancer recurrence among Indigenous and minority peoples. Front Psychol 2021; 12:621850doi: 10.3389/fpsyg.2021.621850.
doi: 10.3389/fpsyg.2021.621850
Bernardes CM, Beesley V, Shahid S, et al. End-of-life care for Aboriginal and Torres Strait Islander people with cancer: an exploratory study of service utilisation and unmet supportive care needs. Support Care Cancer 2021; 29:2073–2082.
Diaz A, Sverdlov AL, Kelly B, et al. Nexus of cancer and cardiovascular disease for Australia's first peoples. J Glob Oncol 2020; 6:115–119.
Davey RX. Health disparities among australia's remote-dwelling Aboriginal people: a report from 2020. J Appl Lab Med 2021; 6:125–141.
Fitzadam S, Lin E, Creighton N, Currow DC. Lung, breast, and bowel cancer treatment for Aboriginal people in New South Wales: a population-based cohort study. Intern Med J 2020; 51:879–890.
Parikh DR, Diaz A, Bernardes C, et al. The utilization of allied and community health services by cancer patients living in regional and remote geographical areas in Australia. Support Care Cancer 2020; 29:3209–3217.
Meiklejohn JA, Bailie R, Adams J, et al. ‘I’m a survivor’: Aboriginal and Torres Strait Islander cancer survivors’ perspectives of cancer survivorship. Cancer Nurs 2020; 43:105–114.
MacDonald EJ, Geller S, Sibanda N, et al. Reaching under-screened/never-screened indigenous peoples with human papilloma virus self-testing: a community-based cluster randomised controlled trial. Aust New Zeal J Obstet Gynaecol 2021; 61:135–141.
Dutton T, Marjoram J, Burgess S, et al. Uptake and acceptability of human papillomavirus self-sampling in rural and remote aboriginal communities: evaluation of a nurse-led community engagement model. BMC Health Serv Res 2020; 20:1–9.
Valery PC, Bernardes CM, de Witt A, et al. Patterns of primary healthcare service use of Indigenous Australians diagnosed with cancer. Support Care Cancer 2020; 28:317–327.
Anderson K, Diaz A, Parikh DR, Garvey G. Accessibility of cancer treatment services for Indigenous Australians in the Northern Territory: perspectives of patients and care providers. BMC Health Serv Res 2021; 21:1–13.
Butler TL, Anderson K, Condon JR, et al. Indigenous Australian women's experiences of participation in cervical screening. PLoS One 2020; 15:1–18.
Read DJ, Frentzas S, Ward L, et al. Do histopathological features of breast cancer in Australian Indigenous women explain the survival disparity? A two decade long study in the Northern Territory. Asia Pac J Clin Oncol 2020; 16:348–355.
Ristevski E, Thompson S, Kingaby S, et al. Understanding aboriginal peoples’ cultural and family connections can help inform the development of culturally appropriate cancer survivorship models of care. J Glob Oncol 2020; 6:124–132.
Allan J, Locke M, Wagener J. Ethnic variability in postmastectomy breast reconstruction in Counties Manukau District Health Board in 2017: a retrospective review. ANZ J Surg 2020; 90:1402–1407.
Blackmore T, Lao C, Chepulis L, et al. The characteristics and outcomes of patients with colorectal cancer in New Zealand, analysed by Cancer Network. N Z Med J 2020; 133:42–52.
Gurney J, Stanley J, Jackson C, Sarfati D. Stage at diagnosis for māori cancer patients: disparities, similarities and data limitations. N Z Med J 2020; 133:43–64.
Egan R, Lawrenson R, Kidd J, et al. Inequalities between Māori and non-Māori men with prostate cancer in Aotearoa New Zealand. N Z Med J 2020; 133:69–76.
Hari Dass P, Jameson MB. Testicular cancer: a 13-year retrospective review of ethnic disparities in the Waikato region, New Zealand. Intern Med J 2020; 50:1344–1349.
Kim DH, Chepulis L, Keenan R, et al. Prevalence of invasive cancer in a large general practice patient population in New Zealand. J Prim Healthcare 2020; 12:215–224.
Latt PM, Tin Tin S, Elwood M, et al. Receipt of radiotherapy after mastectomy in women with breast cancer: population-based cohort study in New Zealand. Asia Pac J Clin Oncol 2020; 16:e99–e107.
Gurney JK, Robson B, Koea J, et al. The most commonly diagnosed and most common causes of cancer death for Māori New Zealanders. N Z Med J 2020; 133:77–96.
Lao C, Kuper-Hommel M, Laking G, et al. Evidence of inequitable use of chemotherapy in New Zealand colorectal cancer patients. N Z Med J 2020; 133:15–26.
Matthews C, Walker M, McLaughlin S, et al. Effect of ethnicity and rurality on treatment delays in patients with colorectal cancer in Northland, New Zealand. ANZ J Surg 2021; 91:375–378.
Matti B, Lyndon M, Zargar-Shoshtari K. Ethnic and socio-economic disparities in prostate cancer screening: lessons from New Zealand. BJU Int 2020; 9–12.
Scott N, Bennett H, Masters-Awatere B, et al. Indigenous cancer research: reflections on roles and responsibilities. J Glob Oncol 2020; 2020:143–147.
Varghese C, Immanuel T, Ruskova A, et al. The epidemiology of myeloproliferative neoplasms in New Zealand between 2010 and 2017: insights from the New Zealand Cancer Registry 2021; 28:1544–1557.
Varghese C, Liu VY, Immanuel T, et al. Ethnic differences in acute promyelocytic leukaemia between New Zealand Polynesian and European patients. Hematology 2021; 26:215–224.
Gurney JK. The puzzling incidence of testicular cancer in New Zealand: what can we learn? Andrology 2019; 7:394–401.
Cancer Australia. Optimal Care Pathway for Aboriginal and Torres Strait Islander people with cancer [Internet]. Canberra (ACT): Cancer Australia; 2018. Available at: https://www.canceraustralia.gov.au/publications-and-resources/cancer-australia-publications/optimal-care-pathway-aboriginal-and-torres-strait-islander-people-cancer . [cited 23 May 2021].

Auteurs

Amy Davies (A)

Department of Oncology, Latrobe Regional Hospital, Traralgon, Victoria, Australia.

Jason Gurney (J)

Cancer and Chronic Conditions (C3) Research Group, Department of Public Health, University of Otago, Wellington, New Zealand.

Gail Garvey (G)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory.
School of Public Health, University of Queensland, Brisbane.

Abbey Diaz (A)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory.

Eva Segelov (E)

Department of Medical Oncology, Monash Health, Melbourne, Victoria.
Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH